Searched for
PHARMA SEZ
PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- Nifty can rally to 30,089 in Prabhudas Lilladher’s bull case scenario, adds 3 stocks to model portfolioDomestic brokerage Prabhudas Lilladher sees Nifty rallying 24% to 30,089 in a bull-case scenario, driven by strength in banks, capital good...
- Lupin seeks more time from commerce ministry to complete Indore SEZ projectCompany is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhal...
- Zydus Cadila gets EIR from USFDA for Pharma SEZ plant at AhmedabadThe company's "formulations manufacturing facility at Pharma SEZ, Ahmedabad has received an EIR from the USFDA signifying the successful cl...
- Dishman to exit SEZ biz, raise Rs 600 croreDishman Pharma scraps its SEZ project. Will sell its SEZ land near Ahmedabad to off its bank debt.
- Four SEZs to receive new investments of Rs 140 crTen companies will start their units in four SEZs of the state following a nod by the zonal director of SEZs. Together they will invest Rs ...
- Dishman Pharma's SEZ to take off after 4-year delaySEZ project of listed entity Dishman Pharmaceuticals & Chemicals to finally take off after a delay of over four years.
- Torrent Group to expand pharma facility, set up SEZIt’s all about expansion at Torrent Group, which has interests in pharma and power.
- Dishman scraps engg SEZ, merges it with pharma projectThe Rs 1,000-crore Dishman Pharmaceuticals & Chemicals Ltd, a contract research and manufacturing services (CRAMS) major, has scrapped its ...
- Dishman plans JVs with up to 10 foreign cosDishman Pharmaceuticals is planning joint ventures with 8-10 global mid-sized companies through joint ventures.
- IL&FS fund buys 30% in JB Pharma SEZIL&FS Realty Fund, a private equity fund managed by Infrastructure Leasing and Financial Services (IL&FS), has picked up 30% stake in JB Ph...
- Goa villagers raise objections for 'God's sake' against SEZWhile SEZs meet with opposition for various reasons across the country, in Goa, Cipla's Meditab specialities Pvt Ltd's pharma SEZ in North ...
- Centre dares Goa, says SEZs once notified cannoat be cancelledCentre has said that the three SEZs notified in the state -- pharma major Cipla’s Meidtab Specialities, Raheja’s IT/ITeS SEZ and Peninsula ...
- Cipla's pharma SEZ runs into trouble in GoaPharma giant Cipla’s plan to develop an SEZ in Goa received another serious jolt on Friday when the north Goa collector ordered removal of ...
- L&T, Man, Chiripal keen to set up SEZs in GujaratIt's 51 and counting. A number of companies including L&T, Man Industries and Chiripal want to set up special economic zones (SEZs) in the ...
- SNF to invest Rs 150 cr in Vizag pharma SEZGlobal pharma and speciality chemical companies are making a beeline for Andhra Pradesh. French chemical major SNF is all set to invest Rs ...
- Tokyo's Eisai to invest Rs 500 cr in Vizag SEZTokyo-based pharma major Eisai has zoomed on India to set up a new Rs 500 crore manufacturing and R&D centre.
- Infy, Suzlon SEZs to get notifiedeGOM green signal will help fast-track projects in Tamil Nadu, Andhra Pradesh and Karnataka.
- Gujarat to host Dishman, Suzlon, Sterling SEZsThe Rs 220-crore Dishman Pharmaceuticals & Chemicals, one of the leading active pharmaceutical ingredient makers in India, is planning to d...
Load More
